{"name":"Cinfa Biotech","slug":"cinfa-biotech","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"B12019 and Neulasta","genericName":"B12019 and Neulasta","slug":"b12019-and-neulasta","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"B12019 and Neulasta","genericName":"B12019 and Neulasta","slug":"b12019-and-neulasta","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxNTFhpLThvSTRhVTBUaW5KQm84b0JJMUlNb1JwRlZGbU9oTWs2TXhFdHM0TTdIX2pPREVPWE1fVGdZRTVRQVI3VzJrV3J5R2plMG1oTzk1OFN5VDdOeElEUFZFOS10akxtbTUwS3UtWWpWWGJaZ3hIenFIRXZoVXQwT24wSm1rVXQ1WmdQN0Z5aGN6Rlh3QWJxUFprcDdQNkJ0VmVmMWVRZDhnRGxCeUpOUTFyTXFYejdOcFRNcndvZmZVTXA0TldlZjFOZ29SN1ZIVXlvSXBiY2lBdw?oc=5","date":"2024-07-30","type":"patent","source":"BioSpace","summary":"Spain Pharmaceutical Market to Reach a CAGR of 5.40% during 2024-2032, Impelled by Increasing Adoption of Generic Drugs - BioSpace","headline":"Spain Pharmaceutical Market to Reach a CAGR of 5.40% during 2024-2032, Impelled by Increasing Adoption of Generic Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQenNOaFhNSGFZU285VExmRGRWYTlEbnBVa1JpZ2JnV19IbVB1Yi1XNnl2bEFXZFBPdFNQT3JTYnd1SEI4QVBrN0hua3diUkRkVDBRajBRREtpaXdsRzN2eWtqZ2JpNlBuTXZ6RDV1UG5IWnZCN2c5cnBHS3lpa0VFc0RTMHZ3UW1Nb1FkaExvaVdaZzZBS01pcWVsZU8ybW1lQjRNaE1weFNQUQ?oc=5","date":"2021-07-02","type":"regulatory","source":"Generics and Biosimilars Initiative","summary":"EC approval for pegfilgrastim biosimilars Pelmeg and Ziextenzo - Generics and Biosimilars Initiative","headline":"EC approval for pegfilgrastim biosimilars Pelmeg and Ziextenzo","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9LSlBac3IzNnoweGtaR21UdVRpMHlQLVlRWjdCN1JzbEtpRC1sckdRYkZVMWRUazhrYVBXSDVmcDl5RTRYWnJxN0UyWkJlTHRUNDZiVVJsMDhGamdXcE9MNmx3WXdDSGxteXpZaU1YRTU1aVEzZWh2aEJnS3VJWE0?oc=5","date":"2021-01-15","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Biosimilars of pegfilgrastim - Generics and Biosimilars Initiative","headline":"Biosimilars of pegfilgrastim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQeTlDTlZlUVNaQlphZFVzeUQ1M0lKVmowT29ZNmRoU2NPemE2cENIRnpqaUtBeEdNUG5yaEV6ZGZpVzdUTG9pZW13MUpWeVloX1NhaExfRnBacHprSU5VcjF3ZzRFYWJ6OHR2WkE2OE9ZaXh2ZFJTaUhNLTZHMFdtU3NSRlZYWDcwX1lRenFFdjJBQVhlTkN6WkNKeEZOVWFMQnlPOGF2aE9MdXNsbFVwaXNn?oc=5","date":"2019-07-01","type":"patent","source":"Center for Biosimilars","summary":"Eye on Pharma: Egis to Distribute Mundipharma's Pelmeg in Eastern Europe - Center for Biosimilars","headline":"Eye on Pharma: Egis to Distribute Mundipharma's Pelmeg in Eastern Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5jU2lUYWEyOXpETXY5blR5WU9lZldfY1paZkp0cW1IMTJnVXFxck9aSVYtUV81UnJSVk5McUxFOEE3Rjk0dlk4eEtJR2MxbFN5YmN0bEZ6S01YN1VjTjNwdUlKbTR2SGV5U2pUanFCSDAyS3VsTHc1Rg?oc=5","date":"2019-03-04","type":"patent","source":"pharmaphorum","summary":"Napp launches Neulasta biosimilar in UK - pharmaphorum","headline":"Napp launches Neulasta biosimilar in UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQbXl5VklndWRxUEpIQVRMOGRkQWpCNVRYaHp3SVVEMXZXX0c4a3JmVkVlaWgzOTNpbFh5OWFfalV6VzNzNm8wc281N0ZhZzcxYUctQ2JqN1BIeUFBcHR6aVpjYmJMV3BnY3k4V3hQdkExcm9kdnFNVjNQaDZ6SVlrS1ZMODRfaXV5OWJvby0yYkUwYTVkaE9sZnBpQWRpOXlQVUY0VHQyUWFmLXhkM2Q2RWpPUkRpakpLLTVzN09rS3JsZVZX?oc=5","date":"2019-02-05","type":"patent","source":"Center for Biosimilars","summary":"Mundipharma Launches Biosimilar Pegfilgrastim in Germany, the Netherlands, and Ireland - Center for Biosimilars","headline":"Mundipharma Launches Biosimilar Pegfilgrastim in Germany, the Netherlands, and Ireland","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNVm5tSEZHaVB0NUV4eDd6OWpNSXFVS01aMkdhWnJZZGFyb2prLThFZjd1a3NUcVc2aXlUX3hLb200cHBqSjlGZy1MRHVnajlxcE51YUF0b295dzlNTUV5QlNONl85VUliSFF5T2ZPUDZBWGxmMnJISnJ4YXZob3ZyTjlmZWY4My12WElGRVlqY2RzaUg3WTBjZQ?oc=5","date":"2018-11-26","type":"regulatory","source":"Pf Media","summary":"EC approve Pelmeg▼® for chemotherapy induced neutropenia - Pf Media","headline":"EC approve Pelmeg▼® for chemotherapy induced neutropenia","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE40SXlPc01Pa3Uzb0lZNzdROUp6UnhMNm51UFZRcnM5TzF2VTdHQVNDdjdZaVNDWTFsbV9XR0pHQS1Cd3U5NnI0Rk9HZmFCWnJmbXgzZVNNWFdnb3VtQVZ4Y3d0a3k5dGl2MVBlVlJSN05XNG0xdkVFbGtYOXpqZw?oc=5","date":"2018-11-20","type":"pipeline","source":"pharmaphorum","summary":"Mundipharma appoints former GSK exec as CFO - pharmaphorum","headline":"Mundipharma appoints former GSK exec as CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPOERKVW9Eck1Nalo3QmItNVdYbkNFV3pBVG9QeFlVQWRlNlVUbGx1UGNvMHZZWVJuSkdsLWZSOHR1VlNNNXlEMWNHZXBQV3p6VUFMQ2tmbm9nQ0N2VEFnR25rVDM1bm5kNXc0ZDQ2TnFwV1QtaDBWci16eHBsSW94WGdPOFhYMmg1SmhjQXhR?oc=5","date":"2018-10-10","type":"deal","source":"pharmaphorum","summary":"Mundipharma buys Spanish biosimilars firm Cinfa Biotech - pharmaphorum","headline":"Mundipharma buys Spanish biosimilars firm Cinfa Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNc3BFMGdGRGRsWnY3QjhieUFiRTF5dHJlbGdjS1NlQVdKRGo4ei16ckRwdl82R0pIVTRyM0loUkc2RldSbnhMa0xjSDNXczRtLWNXamtIWWhxSGtKLXQwajNEQkVPUGRzMUZKZ0NpMC11Mnozd1FKWVlKTi1NcnhFbXpKdE9ubTh5Rl9FNklTdE9nakNxMTNSMQ?oc=5","date":"2018-10-10","type":"deal","source":"Pharmafile","summary":"Sackler-owned Mundipharma acquires biosimilar firm Cinfa Biotech - Pharmafile","headline":"Sackler-owned Mundipharma acquires biosimilar firm Cinfa Biotech","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}